Clinical Trial Update: Detection of Immune Cell Infiltration Into Melanomas Treated by PV-10, a Feasibility Study [Phase 1]

View source ↗

Summary

Phase 1 feasibility study evaluating PV-10 in melanoma with a focus on immune cell infiltration has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma

Drugs mentioned

• PV-10 (Rose Bengal disodium)

Snippet

Sponsor: H. Lee Moffitt Cancer Center and Research Institute | Conditions: Melanoma | Phase 1 | Status: COMPLETED